Company
Headquarters: Bangkok, Thailand
CEO: Mr. Chairat Panthuraamphorn M.D.
฿43.00 Billion
THB as of Dec. 1, 2022
US$1.24 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Samitivej Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand and internationally. The company operates in two segments, Hospital Operations and Other Businesses. It operates hospitals, as well as offers various programs and services to personalize the healthcare experiences; and medical services to large corporations, embassies, and international schools. The company also provides asset management services for healthcare business; distributes health and cosmetics products; and operates a clinic. In addition, it engages in the facility management and investment activities. The company was founded in 1979 and is based in Bangkok, Thailand. Samitivej Public Company Limited is a subsidiary of Bangkok Dusit Medical Services Public Company Limited.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Samitivej Public Company Ltd has the following listings and related stock indices.
Stock: SET: SVH wb_incandescent
Stock: SET: SVH.R wb_incandescent